|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1990-9-25
|
|
pubmed:abstractText |
Patients with transfusion-dependent thalassemia major tend to have abnormal growth and sexual maturation at puberty, presumably as a result of pituitary iron overload. This study was designed to determine whether chelation therapy with deferoxamine before the age of puberty would ameliorate this problem.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
13
|
|
pubmed:volume |
323
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
713-9
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:2388669-Adolescent,
pubmed-meshheading:2388669-Age Factors,
pubmed-meshheading:2388669-Body Height,
pubmed-meshheading:2388669-Child,
pubmed-meshheading:2388669-Deferoxamine,
pubmed-meshheading:2388669-Female,
pubmed-meshheading:2388669-Ferritins,
pubmed-meshheading:2388669-Growth Hormone,
pubmed-meshheading:2388669-Humans,
pubmed-meshheading:2388669-Iron Chelating Agents,
pubmed-meshheading:2388669-Luteinizing Hormone,
pubmed-meshheading:2388669-Male,
pubmed-meshheading:2388669-Puberty,
pubmed-meshheading:2388669-Sexual Maturation,
pubmed-meshheading:2388669-Thalassemia
|
|
pubmed:year |
1990
|
|
pubmed:articleTitle |
Effect of age at the start of iron chelation therapy on gonadal function in beta-thalassemia major.
|
|
pubmed:affiliation |
Division of Endocrinology, Hospital for Sick Children, Toronto, Canada.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
